Clinical Trials Browser

Uterine Cervical Neoplasms × toripalimab × 30 days × Clear all

NCT04651127 2026-03-10

Anti-PD-1 Antibody Combined With Histone Deacetylase Inhibitor in Patients With Advanced Cervical Cancer

Phase 1/2 Terminated

Uterine Cervical Neoplasms